Procaps Group Reports Second Quarter and First Half 2022 Results
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Procaps Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
FinancialNewsMedia.com News Commentary PALM BEACH, Fla., June 29, 2022 /PRNewswire/ -- In the central nervous system (CNS) therapeutics market, large and small pharmaceutical companies
/PRNewswire/ -- In the central nervous system (CNS) therapeutics market, large and small pharmaceutical companies are highly investing in the development of...
Procaps Group (NASDAQ:PROC – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Friday, Zacks.com reports. According to Zacks, “Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets […]
Research Analysts’ upgrades for Friday, June 10th: Aryzta (OTCMKTS:ARZTF) was upgraded by analysts at Cheuvreux to a hold rating. Comcast (NASDAQ:CMCSA) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating. CME Group (NASDAQ:CME) was upgraded by analysts at Atlantic Securities from a neutral rating to an overweight rating. The firm […]